H. Khanlou

发表

The Major Genetic Determinants of HIV-1 Control Affect HLA Class I Peptide Presentation

Jack T Stapleton, Stuart Haber, David Heckerman, 2010, Science.

H. Khanlou, S. Sayana, 2009, Expert review of anti-infective therapy.

Safety and Efficacy of Autologous CD34+ Hematopoietic Progenitor Cells Transduced with an Anti-Tat Ribozyme in a Multi-Center, Randomized, Placebo-Controlled, Phase II Gene Therapy Trial for the Human Immunodeficiency Virus

C. von Kalle, T. Merigan, M. Winters, 2009, Nature Medicine.

SWIFT: Prospective 48-Week Study to Evaluate Efficacy and Safety of Switching to Emtricitabine/Tenofovir From Lamivudine/Abacavir in Virologically Suppressed HIV-1 Infected Patients on a Boosted Protease Inhibitor Containing Antiretroviral Regimen

U. Bredeek, E. Dejesus, H. Khanlou, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Impact of Switch to Fosamprenavir and Addition of Lovaza ® for Treatment of Hypertriglyceridemia in HIV-Infected Subjects on Antiretroviral Therapy

B. Ha, H. Khanlou, L. Ross, 2012 .

TMP/SMX is still the preferred empiric antibiotic for methicillin-resistant Staphylococcus aureus skin and soft tissue infection in the HIV population.

H. Khanlou, Gina M Simoncini, 2012, Journal of acquired immune deficiency syndromes.

The safety and efficacy of dose-sparing intradermal administration of influenza vaccine in human immunodeficiency virus-positive patients.

C. Farthing, S. Sanchez, H. Khanlou, 2006, Archives of internal medicine.

Phase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34+ cells.

Christof von Kalle, Roger Garsia, Robert Finlayson, 2009, Nature medicine.

Darunavir: a new HIV-1 protease inhibitor for the treatment of HIV infection

H. Khanlou, S. Sayana, 2008 .

Final 192‐week efficacy and safety of once‐daily darunavir/ritonavir compared with lopinavir/ritonavir in HIV‐1‐infected treatment‐naïve patients in the ARTEMIS trial

C. Orkin, T. van de Casteele, E. Dejesus, 2013, HIV medicine.

False-positivity of HIV-2 immunoblots in a cohort of elite suppressors infected with HIV-1.

H. Khanlou, Mehri S McKellar, Pam Jongthavorn, 2008, Journal of acquired immune deficiency syndromes.

Efficacy and safety of once-daily darunavir/ritonavir versus lopinavir/ritonavir in treatment-naive HIV-1-infected patients at week 48

J. van Lunzen, E. Dejesus, H. Khanlou, 2008, AIDS.

Immunomodulation of antiretroviral drug-suppressed chronic HIV-1 infection in an oral probiotic double-blind placebo-controlled trial.

O. Yang, T. Kelesidis, H. Khanlou, 2014, AIDS research and human retroviruses.

ARTEMIS: 192-week efficacy and safety of once-daily darunavir/ritonavir (DRV/r) vs lopinavir/r (LPV/r) in treatment-naïve HIV-1-infected adults

C. Orkin, T. van de Casteele, E. Dejesus, 2010, Journal of the International AIDS Society.

Peripheral Neuropathy Induced by Lopinavir-Saquinavir-Ritonavir Combination Therapy in an HIV-Infected Patient

C. Farthing, H. Khanlou, Miguel Valdes-Sueiras, 2007, Journal of the International Association of Physicians in AIDS Care.

Clinic-based testing for rectal and pharyngeal Neisseria gonorrhoeae and Chlamydia trachomatis infections by community-based organizations--five cities, United States, 2007.

M. Golden, C. Kent, M. Pandori, 2009, MMWR. Morbidity and mortality weekly report.

Barriers and unmet need for supportive services for HIV patients in care in Los Angeles County, California.

E. Daar, J. Tejero, A. Wohl, 2011, AIDS patient care and STDs.

Clinical impact and cost of laboratory monitoring need review even in resource-rich setting.

M. Javanbakht, H. Khanlou, S. Sayana, 2011, Journal of acquired immune deficiency syndromes.

Documentation of Psychiatric Disorders and Related Factors in a Large Sample Population of HIV-Positive Patients in California

T. Fong, H. Khanlou, Iman Parhami, 2013, AIDS and Behavior.

Meningitis Due to Hematogenous Dissemination of Community-Associated Methicillin-Resistant Staphylococcus aureus (MRSA) in a Patient With AIDS

H. Khanlou, S. Sayana, 2008, Journal of the International Association of Physicians in AIDS Care.

Erratum: SWIFT: Prospective 48-week study to evaluate efficacy and safety of switching to emtricitabine/tenofovir from lamivudine/abacavir in virologically suppressed HIV-1 infected patients on a boosted protease inhibitor containing antiretroviral regimen (Clinical Infectious Diseases (2013) 56:11

U. Bredeek, E. Dejesus, H. Khanlou, 2013 .

An unusual pathogen for a liver abscess in a human immunodeficiency virus-infected individual.

H. Khanlou, S. Sayana, J. Ricaurte, 2010, The American journal of the medical sciences.

Use of Maraviroc-, Raltegravir-, and Etravirine-Containing Regimens in Treatment-Experienced Patients: A Case-Series Study

H. Khanlou, S. Sayana, C. Youngblood, 2011, Journal of the International Association of Physicians in AIDS Care.

The 104 day report: a successful intervention of improving patient retention.

M. Javanbakht, H. Khanlou, S. Sayana, 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Q Fever, Free Amoeba, and Air Conditioning Oral Voriconazole Dose in Children: One Size Does Not Fit All

M. Javanbakht, H. Khanlou, S. Sayana, 2010 .

D. Ward, K. Mounzer, M. Gottlieb, 2011, HIV clinical trials.

Efficacy and safety of switching suppressed patients with elevated triglycerides from lopinavir/ritonavir or fosamprenavir/ritonavir to atazanavir/ritonavir or darunavir/ritonavir based therapy: The LARD study

K. Mounzer, D. Skiest, C. Cohen, 2012 .

The Major Genetic Determinants of HIV-1 Control Affect HLA Class I Peptide Presentation

R. C. Rose, Todd M. Allen, David S. Rubin, 2010, Science.

Analysis of a Switch From Enfuvirtide to Raltegravir in Patients With Undetectable Viral Load: Efficacy and Quality of Life at 24 Weeks

S. Sanchez, H. Khanlou, S. Sayana, 2009, Journal of the International Association of Physicians in AIDS Care.

[Characteristics of rapid progressors in HIV infection].

H. Khanlou, D. Salmon-Céron, Didier Sicard, 1997, Annales de medecine interne.